SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Windlas Biotech - Quaterly Results

08 Feb 2023 Evaluate
The quarter ended December 2022 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 1197.04 millions.A humble growth in net profit of 10.50% reported in the quarter ended December 2022 to Rs. 91.88  millions from Rs. 83.15 millions.Operating profit surged to 161.11 millions from the corresponding previous quarter of 148.36 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1197.04 1175.91 1.80 3723.70 3437.99 8.31 4659.30 4276.02 8.96
Other Income 21.62 17.93 20.58 76.31 37.01 106.19 67.06 30.94 116.74
PBIDT 161.11 148.36 8.59 514.31 423.11 21.55 596.01 577.86 3.14
Interest 1.57 2.11 -25.59 6.22 11.29 -44.91 14.17 12.90 9.84
PBDT 159.54 146.25 9.09 508.09 411.82 23.38 581.84 241.45 140.98
Depreciation 31.35 31.45 -0.32 87.96 92.45 -4.86 121.47 129.65 -6.31
PBT 128.19 114.80 11.66 420.13 319.37 31.55 460.37 111.80 311.78
TAX 36.31 31.65 14.72 108.16 86.09 25.64 74.76 61.70 21.17
Deferred Tax 8.65 4.12 109.95 6.75 1.93 249.74 -26.57 13.28 -300.08
PAT 91.88 83.15 10.50 311.97 233.28 33.73 385.61 50.10 669.68
Equity 107.21 108.97 -1.62 108.97 108.97 0.00 108.97 64.11 69.97
PBIDTM(%) 13.46 12.62 6.68 13.81 12.31 12.23 12.79 13.51 -5.34

Windlas Biotech Share Price

874.75 9.35 (1.08%)
20-Apr-2026 14:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.75
Dr. Reddys Lab 1233.95
Cipla 1231.60
Zydus Lifesciences 938.70
Lupin 2328.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×